Hepatitis C | Podcast

Overview

Ninja Nerd's podcast episode on Hepatitis C details its transmission primarily through blood and vertical routes, emphasizing the lack of a vaccine due to the virus's antigenic variation. The discussion highlights that Hepatitis C is often asymptomatic, leading to delayed diagnosis and potential chronic liver damage, cirrhosis, and hepatocellular carcinoma. Treatment involves pangenotypic direct-acting antivirals, typically a combination of two drugs, with a high cure rate and sustained virological response (SVR) as the goal.

Key takeaways

Hepatitis C's high antigenic variation, due to a lack of proofreading in its RNA polymerase, prevents the immune system from clearing it and makes vaccine development challenging.
Universal screening for Hepatitis C is recommended for all adults at least once, and during pregnancy, as the infection is often asymptomatic for decades.
Diagnosis requires a positive Hepatitis C antibody test followed by a positive HCV RNA test to confirm active replication; a negative HCV RNA indicates resolved infection.
Treatment for Hepatitis C involves 8-12 weeks of pangenotypic direct-acting antivirals, achieving a sustained virological response (SVR) in most patients.
Patients with cirrhosis due to Hepatitis C require lifelong screening for hepatocellular carcinoma every six months via ultrasound and AFP levels.
Sofosbuvir can increase amiodarone levels, potentially causing bradycardia, and proton pump inhibitors may decrease the absorption and efficacy of velpatasvir.

Chapters

0:00 Hepatitis C: Etiology, Transmission, and Antigenic Variation

Hepatitis C is primarily transmitted via blood (IV drug use, needle sticks) and vertically from mother to child.
Prior to 1992, blood transfusions were a risk, but this is now rare.
The virus exhibits significant antigenic variation due to a faulty RNA-dependent RNA polymerase, preventing effective immune clearance and vaccine development.

10:00 Diagnosis and Treatment of Hepatitis C

Screening is recommended at least once in a lifetime for individuals 18 years and older, and during pregnancy.
Diagnosis involves Hepatitis C antibody testing, followed by HCV RNA to confirm active infection.
Treatment utilizes pangenotypic direct-acting antivirals (e.g., NS3/4A protease inhibitors, NS5A inhibitors, NS5B inhibitors) for 8-12 weeks.

18:37 Managing Advanced Hepatitis C and Drug Interactions

Patients with significant fibrosis or cirrhosis require regular screening for hepatocellular carcinoma (ultrasound, AFP every 6 months).
Cirrhosis is generally irreversible, but treatment aims to prevent further complications like portal hypertension and declining liver function.
Key drug interactions include amiodarone (risk of bradycardia with sofosbuvir) and proton pump inhibitors (reduced absorption of velpatasvir).

Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, Ninja Nerd.